Doctor Arman Qamar
Brigham and Women's Hospital, Boston (United States of America)
Efficacy and safety of edoxaban vs. warfarin in patients with atrial fibrillation and hepatic disease: Insights from the ENGAGE AF-TIMI 48 trial
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Stroke prevention
ESC 365 is supported by
